{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:38:29Z","timestamp":1776371909744,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0446-0","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T10:54:18Z","timestamp":1438167258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas"],"prefix":"10.1186","volume":"10","author":[{"given":"Motomasa","family":"Furuse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naosuke","family":"Nonoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichiro","family":"Toho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Ichi","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"446_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.10.053","volume":"75","author":"C Boskos","year":"2009","unstructured":"Boskos C, Feuvret L, Noel G, Habrand JL, Pommier P, Alapetite C, et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys. 2009;75:399\u2013406.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"446_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.radonc.2009.12.029","volume":"95","author":"SE Combs","year":"2010","unstructured":"Combs SE, Hartmann C, Nikoghosyan A, J\u00e4kel O, Karger CP, Haberer T, et al. Carbon ion radiation therapy for high-risk meningiomas. Radiother Oncol. 2010;95:54\u20139.","journal-title":"Radiother Oncol"},{"key":"446_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3171\/2013.5.JNS122204","volume":"119","author":"S Kawabata","year":"2013","unstructured":"Kawabata S, Hiramatsu R, Kuroiwa T, Ono K, Miyatake S. Boron neutron capture therapy for recurrent high-grade meningiomas. J Neurosurg. 2013;119:837\u201344.","journal-title":"J Neurosurg"},{"key":"446_CR4","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/annonc\/mdq634","volume":"21","author":"MJA Puchner","year":"2010","unstructured":"Puchner MJA, Hans VH, Harati A, Lohmann F, Glas M, Herrlinger U. Bevacizumab-induced regression of anaplastic meningioma. Ann Oncol. 2010;21:2445\u20136.","journal-title":"Ann Oncol"},{"key":"446_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11060-012-0861-0","volume":"109","author":"E Lou","year":"2012","unstructured":"Lou E, Sumrall AL, Turner S, Peters KB, Desjardins A, Vrendenburgh JJ, et al. Bevacizumab therapy for adults with recurrent\/progressive meningioma: a retrospective series. J Neurooncol. 2012;109:63\u201370.","journal-title":"J Neurooncol"},{"key":"446_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","volume":"67","author":"J Gonzalez","year":"2007","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007;67:323\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"446_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11060-009-9801-z","volume":"94","author":"R Torcuator","year":"2009","unstructured":"Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol. 2009;94:63\u20138.","journal-title":"J Neurooncol"},{"key":"446_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79:1487\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"446_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11060-010-0333-3","volume":"102","author":"M Furuse","year":"2011","unstructured":"Furuse M, Kawabata S, Kuroiwa T, Miyatake S. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neurooncol. 2011;102:471\u20135.","journal-title":"J Neurooncol"},{"key":"446_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/jjco\/hys231","volume":"43","author":"M Furuse","year":"2013","unstructured":"Furuse M, Nonoguchi N, Kawabata S, Yoritsune E, Takahashi M, Inomata T, et al. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. Jpn J Clin Oncol. 2013;43:337\u201341.","journal-title":"Jpn J Clin Oncol"},{"key":"446_CR11","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1158\/1078-0432.CCR-03-0426","volume":"10","author":"RA Nordal","year":"2004","unstructured":"Nordal RA, Nagy A, Pintillie M. Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Cin Cancer Res. 2004;10:3342\u201353.","journal-title":"Cin Cancer Res"},{"key":"446_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11060-011-0610-9","volume":"105","author":"N Nonoguchi","year":"2011","unstructured":"Nonoguchi N, Miyatake SI, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, et al. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol. 2011;105:423\u201331.","journal-title":"J Neurooncol"},{"key":"446_CR13","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/00006123-199705000-00027","volume":"40","author":"J Provias","year":"1997","unstructured":"Provias J, Claffey K, del Aguila L, Lau N, Feldkamp M, Guha A. Meningiomas: role of vascular endothelial growth factor\/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery. 1997;40:1016\u201326.","journal-title":"Neurosurgery"},{"key":"446_CR14","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1212\/01.WNL.0000118300.82017.F4","volume":"62","author":"MC Chamberlain","year":"2004","unstructured":"Chamberlain MC, Tsao-Wei DD, Groshen S. Temozolomide for treatment-resistant recurrent meningioma. Neurology. 2004;62:1210\u20132.","journal-title":"Neurology"},{"key":"446_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","volume":"96","author":"AD Norden","year":"2010","unstructured":"Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, et al. Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol. 2010;96:211\u20137.","journal-title":"J Neurooncol"},{"key":"446_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1215\/15228517-2009-010","volume":"11","author":"PY Wen","year":"2009","unstructured":"Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, et al. Phase II study of imatinib mesylate for recurrent meningiomas (North American brain tumor consortium study 01-08). Neuro Oncol. 2009;11:853\u201360.","journal-title":"Neuro Oncol"},{"key":"446_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/annonc\/mdr012","volume":"22","author":"S Goutagny","year":"2011","unstructured":"Goutagny S, Raymond E, Sterkers O, Colombani JM, Kalamarides M. Radiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab. Ann Oncol. 2011;22:990\u20131.","journal-title":"Ann Oncol"},{"key":"446_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11060-012-0886-4","volume":"109","author":"L Nayak","year":"2012","unstructured":"Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J, et al. Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol. 2012;109:187\u201393.","journal-title":"J Neurooncol"},{"key":"446_CR19","doi-asserted-by":"publisher","first-page":"e59941","DOI":"10.1371\/journal.pone.0059941","volume":"8","author":"FP Nunes","year":"2013","unstructured":"Nunes FP, Merker VL, Jennings D, Caruso PA, di Tomaso E, Muzikansky A, et al. Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients. PLoS One. 2013;8:e59941.","journal-title":"PLoS One"},{"key":"446_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s00066-013-0505-0","volume":"190","author":"JP Bostr\u00f6m","year":"2014","unstructured":"Bostr\u00f6m JP, Seifert M, Greschus S, Sch\u00e4fer N, Glas M, Lammering G, et al. Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study. Strahlenther Onkol. 2014;190:416\u201321.","journal-title":"Strahlenther Onkol"},{"key":"446_CR21","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28:1963\u201372.","journal-title":"J Clin Oncol"},{"key":"446_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s00259-009-1133-x","volume":"36","author":"JW Lee","year":"2009","unstructured":"Lee JW, Kang KW, Park SH, Lee SM, Paeng JC, Chung JK, et al. 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging. 2009;36:1574\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"446_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s12149-013-0747-z","volume":"27","author":"H Ikeda","year":"2013","unstructured":"Ikeda H, Tsuyuguchi N, Kunihiro N, Ishibashi K, Goto T, Ohata K. Analysis of progression and recurrence of meningioma using (11)C-methionine PET. Ann Nucl Med. 2013;27:772\u201380.","journal-title":"Ann Nucl Med"},{"key":"446_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1227\/01.neu.0000279727.90650.24","volume":"61","author":"S Miyatake","year":"2007","unstructured":"Miyatake S, Tamura Y, Kawabata S, Iida K, Kuroiwa T, Ono K. Boron neutron capture therapy for malignant tumors related to meningiomas. Neurosurgery. 2007;61:82\u201390.","journal-title":"Neurosurgery"},{"key":"446_CR25","first-page":"201","volume":"25","author":"PA Hein","year":"2004","unstructured":"Hein PA, Eskey CJ, Dunn JF, Hug EB. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol. 2004;25:201\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"key":"446_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/neuonc\/nor075","volume":"13","author":"J Narang","year":"2011","unstructured":"Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, et al. Differentiating treatment-induced necrosis from recurrent\/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro-Oncol. 2011;13:1037\u201346.","journal-title":"Neuro-Oncol"},{"key":"446_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1148\/radiol.14141414","volume":"275","author":"JE Park","year":"2015","unstructured":"Park JE, Kim HS, Goh MJ, Kim SJ, Kim JH. Pseudoprogression in patients with glioblastoma: assessment by using volume-weighted voxel-based multiparametric clustering of MR imaging data in an independent test set. Radiology. 2015;275:792\u2013802.","journal-title":"Radiology"},{"key":"446_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/A:1021186401522","volume":"60","author":"SH Paek","year":"2002","unstructured":"Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, et al. Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol. 2002;60:235\u201345.","journal-title":"J Neurooncol"},{"key":"446_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11060-008-9588-3","volume":"89","author":"AT Panagopoulos","year":"2008","unstructured":"Panagopoulos AT, Lancellotti CL, Veiga JC, de Aguiar PH, Colquhoun A. Expression of cell adhesion proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas. J Neurooncol. 2008;89:73\u201387.","journal-title":"J Neurooncol"},{"key":"446_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11060-004-9164-4","volume":"70","author":"S Otsuka","year":"2004","unstructured":"Otsuka S, Tamiya T, Ono Y, Michiue H, Kurozumi K, Daido S, et al. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol. 2004;70:349\u201357.","journal-title":"J Neurooncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0446-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-015-0446-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0446-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0446-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:42:00Z","timestamp":1553640120000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-015-0446-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0446-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"assertion":[{"value":"26 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"156"}}